1. Ma, Wenlong, Chen, Ke, Xiao, Wenqing, Wang, Shaohui, Wang, Kunzheng. . Evaluation of relationship between SPON1 gene and genetic susceptibility of postmenopausal osteoporosis. In Artificial cells, nanomedicine, and biotechnology, 48, 818-823. doi:10.1080/21691401.2020.1771350. https://pubmed.ncbi.nlm.nih.gov/32484721/
2. Nagasawa, Saya, Ikeda, Kazuhiro, Shintani, Daisuke, Horie, Kuniko, Inoue, Satoshi. 2022. Identification of a Novel Oncogenic Fusion Gene SPON1-TRIM29 in Clinical Ovarian Cancer That Promotes Cell and Tumor Growth and Enhances Chemoresistance in A2780 Cells. In International journal of molecular sciences, 23, . doi:10.3390/ijms23020689. https://pubmed.ncbi.nlm.nih.gov/35054873/
3. Huo, Yanmiao, Yang, Jian, Zheng, Jiahao, Hu, Lipeng, Liu, Wei. 2022. Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling. In Cell proliferation, 55, e13237. doi:10.1111/cpr.13237. https://pubmed.ncbi.nlm.nih.gov/35487760/
4. Shah, Amil M, Myhre, Peder L, Arthur, Victoria, Omland, Torbjørn, Yu, Bing. 2024. Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development. In Nature communications, 15, 528. doi:10.1038/s41467-023-44680-3. https://pubmed.ncbi.nlm.nih.gov/38225249/
5. Miyakawa, Ryoya, Kobayashi, Makoto, Sugimoto, Kotaro, Fujimori, Keiya, Chiba, Hideki. 2023. SPON1 is an independent prognostic biomarker for ovarian cancer. In Journal of ovarian research, 16, 95. doi:10.1186/s13048-023-01180-8. https://pubmed.ncbi.nlm.nih.gov/37179355/
智鼠故事 
